VYNE Therapeutics (VYNE) announced positive results from the multiple ascending dose, MAD, portion of its Phase 1a SAD/MAD trial of VYN202. The Phase 1a trial was a two-part, double-blind ...
A family in Andhra Pradesh received a parcel containing a decomposing body and an extortion letter demanding Rs 1.36 crore. The letter linked the demand to a loan allegedly taken by the recipient ...
The Phase 1a trial was a two-part, double-blind, placebo-controlled dose-escalation study in healthy volunteers consisting of single ascending dose (“SAD”) and MAD components to evaluate the ...